Anne-Segolene C.
- Country
- France
- Department
- Nuclear Medecine
Research Overview
- A pivotal phase 3 clinical trial to assess the diagnostic performance and safety of [68Ga]Ga-PentixaFor ([68Ga]Ga-PTF), a positron emission tomography (PET) imaging agent, versus [18F]FDG PET/CT imaging, for staging of patients with confirmed marginal zone lymphoma (MZL) exemplary for CXCR4-positive malignant lymphomas: a prospective, international, multi-center, comparative, randomized, cross-over, open-label lymphoma diagnostic trial (LYMFOR).
- Evaluation of [68Ga]Ga-PentixaFor PET Imaging for Detecting Unilateral Adrenal Aldosterone Secretion in Primary Aldosteronism Patients
Data & Insights
Has run more than one trial at 1 of 20 partner sites.
Specializations
Endocrine Disorders
Specializes in the investigation of primary aldosteronism, focusing on innovative diagnostic approaches using advanced imaging techniques. The investigator explores adrenal gland secretion patterns and their role in hormonal disorders.
- Adrenal Imaging Techniques
- Hormonal Secretion Assessment
- Endocrine Diagnostics
Utilizes specialized PET imaging methodologies to evaluate adrenal function and hormone production patterns.
Oncological Imaging
Conducts research in advanced imaging methodologies for marginal zone lymphoma, employing cutting-edge PET/CT techniques for tumor detection and staging.
- Lymphoma Staging
- PET/CT Imaging
- Tumor Detection Methods
Focuses on comparative imaging techniques to enhance diagnostic accuracy in lymphoma assessment.
Nuclear Medicine
Expertise in radiopharmaceutical imaging applications, particularly utilizing novel tracers for both endocrine and oncological conditions.
- Novel Tracer Development
- Diagnostic Imaging
- Clinical Applications
Implements advanced nuclear medicine techniques for precise disease characterization and diagnosis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.